Prof. Dr. Ijeoma F. Uchegbu obtained her Ph.D. from the School of Pharmacy, University of London. She is currently a Professor of Pharmaceutical Nanoscience at the UCL School of Pharmacy, University College London (UCL), the UCL’s Pro-Vice Provost for Africa and The Middle East, the Provost’ Envoy for Race Equality and Chief Scientific Officer of Nanomerics Ltd., which is a UCL spin-out company. Prof. Dr. Uchegbu’s research in the Pharmaceutical Nanoscience group exploits fundamental physical chemistry
principles to fabricate functional pharmaceutical nanoparticles—nanomedicines. She has been awarded various prizes for her work, notably, the UK Department for Business Innovation Skills’ Women of Outstanding Achievement in Science Engineering and Technology award, the Royal Pharmaceutical
Society’s Pharmaceutical Scientist of the Year 2012 and the Academy of Pharmaceutical Sciences Innovative Science Award 2016. She was elected to the Controlled Release Society College of Fellows in 2013 and was made an Eminent Fellow of the Academy of Pharmaceutical Sciences in 2013. She was also elected as a Fellow of the Academy of Medical Sciences in 2021 and was made an Honorary Fellow of the Royal Society of Chemistry in 2022. She is also a Wellcome governor and sits on the Wellcome board.
Prof. Dr. Ijeoma F. Uchegbu obtained her Ph.D. from the School of Pharmacy, University of London. She is currently a Professor of Pharmaceutical Nanoscience at the UCL School of Pharmacy, University College London (UCL), the UCL’s Pro-Vice Provost for Africa and The Middle East, the Provost’ Envoy for Race Equality and Chief Scientific Officer of Nanomerics Ltd., which is a UCL spin-out company. Prof. Dr. Uchegbu’s research in the Pharmaceutical Nanoscience group exploits fundamental physical chemistry
principles to fabricate functional pharmaceutical nanoparticles—nanomedicines. She has been awarded various prizes for her work, notably, the UK Department for Business Innovation Skills’ Women of Outstanding Achievement in Science Engineering and Technology award, the Royal Pharmaceutical
Society’s Pharmaceutical Scientist of the Year 2012 and the Academy of Pharmaceutical Sciences Innovative Science Award 2016. She was elected to the Controlled Release Society College of Fellows in 2013 and was made an Eminent Fellow of the Academy of Pharmaceutical Sciences in 2013. She was also elected as a Fellow of the Academy of Medical Sciences in 2021 and was made an Honorary Fellow of the Royal Society of Chemistry in 2022. She is also a Wellcome governor and sits on the Wellcome board.